ArticleInternational journal of molecular sciences2024

Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal Astrocytes.

Wioletta Rozpędek-Kamińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.